Key Drivers
- High reported earnings
- Negative operating cashflow
- Very high leverage
AIAI Summary
NMR is no longer just “cheap” on accounting multiples but a capital-structure and execution gamble—speculative NMR-gyroscope upside is secondary to the urgent need for consecutive quarters of positive operating cash flow and a credible deleveraging plan to avoid material downside from extreme leverage and financing dependence.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High reported earnings
- •Negative operating cashflow
- •Very high leverage
NMR posts strong reported profitability and low P/E/P/B but is undermined by deeply negative operating/free cash flow, extreme debt reliance, and very low asset efficiency, so prioritize cash-flow and solvency due diligence before considering investment.
Price Behavior
Key Price Behavior Insights:
- •Downtrend sustained
- •Narrow consolidation
- •Weakening momentum
Over the last month the stock is in a clear downtrend—dropping from $9.23 to $7.54 with the 21-day SMA near $8.17 while it consolidates between $7.40–$7.88; a close below $7.40 risks more downside, while reclaiming $8.17–$8.20 is needed to re-establish an uptrend.
Sharp decline from $9.23 (2026-02-20) to $7.54 (2026-03-20) over the last month
Sentiment & News
Key News Insights:
- •NMR gyroscope
- •Hardware tailwinds
- •Geopolitical volatility
Viewbix's Quantum X Labs filed a provisional patent for a lower-cost, high-precision NMR gyroscope amid Nomura-led investor focus on hardware/semiconductor capex and cautious macro/geopolitical headwinds.
The patent milestone and rising AI-driven chip capex could boost demand prospects for NMR-related hardware providers, though near-term equity performance may be capped by geopolitical uncertainty
Similar Companies in Financial Services
Other companies in the same sector with AI ratings